463 related articles for article (PubMed ID: 26732163)
21. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states.
Agarwal SK; Kester MB; Debelenko LV; Heppner C; Emmert-Buck MR; Skarulis MC; Doppman JL; Kim YS; Lubensky IA; Zhuang Z; Green JS; Guru SC; Manickam P; Olufemi SE; Liotta LA; Chandrasekharappa SC; Collins FS; Spiegel AM; Burns AL; Marx SJ
Hum Mol Genet; 1997 Jul; 6(7):1169-75. PubMed ID: 9215689
[TBL] [Abstract][Full Text] [Related]
22. Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
Luzi E; Marini F; Tognarini I; Carbonell Sala S; Galli G; Falchetti A; Brandi ML
Cancer Gene Ther; 2010 Nov; 17(11):814-25. PubMed ID: 20706287
[TBL] [Abstract][Full Text] [Related]
23. Role of miR-24 in Multiple Endocrine Neoplasia Type 1: A Potential Target for Molecular Therapy.
Marini F; Brandi ML
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298972
[TBL] [Abstract][Full Text] [Related]
24. Multi-omics analyses of MEN1 missense mutations identify disruption of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity.
Dreijerink KMA; Ozyerli-Goknar E; Koidl S; van der Lelij EJ; van den Heuvel P; Kooijman JJ; Biniossek ML; Rodenburg KW; Nizamuddin S; Timmers HTM
Epigenetics Chromatin; 2022 Aug; 15(1):29. PubMed ID: 35941657
[TBL] [Abstract][Full Text] [Related]
25. Multiple endocrine neoplasia type 1: analysis of germline MEN1 mutations in the Italian multicenter MEN1 patient database.
Marini F; Giusti F; Fossi C; Cioppi F; Cianferotti L; Masi L; Boaretto F; Zovato S; Cetani F; Colao A; Davì MV; Faggiano A; Fanciulli G; Ferolla P; Ferone D; Loli P; Mantero F; Marcocci C; Opocher G; Beck-Peccoz P; Persani L; Scillitani A; Guizzardi F; Spada A; Tomassetti P; Tonelli F; Brandi ML
Endocrine; 2018 Oct; 62(1):215-233. PubMed ID: 29497973
[TBL] [Abstract][Full Text] [Related]
26. Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1.
Guo SS; Sawicki MP
Mol Endocrinol; 2001 Oct; 15(10):1653-64. PubMed ID: 11579199
[TBL] [Abstract][Full Text] [Related]
27. Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway.
Yaguchi H; Ohkura N; Takahashi M; Nagamura Y; Kitabayashi I; Tsukada T
Mol Cell Biol; 2004 Aug; 24(15):6569-80. PubMed ID: 15254225
[TBL] [Abstract][Full Text] [Related]
28. Mutation of the MENIN gene in sporadic pancreatic endocrine tumors.
Wang EH; Ebrahimi SA; Wu AY; Kashefi C; Passaro E; Sawicki MP
Cancer Res; 1998 Oct; 58(19):4417-20. PubMed ID: 9766672
[TBL] [Abstract][Full Text] [Related]
29. MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells.
Bazzi W; Renon M; Vercherat C; Hamze Z; Lacheretz-Bernigaud A; Wang H; Blanc M; Roche C; Calender A; Chayvialle JA; Scoazec JY; Cordier-Bussat M
Gastroenterology; 2008 Nov; 135(5):1698-1709.e2. PubMed ID: 18775714
[TBL] [Abstract][Full Text] [Related]
30. MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.
Grolmusz VK; Borka K; Kövesdi A; Németh K; Balogh K; Dékány C; Kiss A; Szentpéteri A; Sármán B; Somogyi A; Csajbók É; Valkusz Z; Tóth M; Igaz P; Rácz K; Patócs A
Virchows Arch; 2017 Sep; 471(3):401-411. PubMed ID: 28597079
[TBL] [Abstract][Full Text] [Related]
31. Germline mutation of the multiple endocrine neoplasia type 1 (MEN1) gene in a family with primary hyperparathyroidism.
Ohye H; Sato M; Matsubara S; Miyauchi A; Imachi H; Murao K; Takahara J
Endocr J; 1998 Dec; 45(6):719-23. PubMed ID: 10395226
[TBL] [Abstract][Full Text] [Related]
32. Impaired transforming growth factor-β (TGF-β) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1).
Canaff L; Vanbellinghen JF; Kaji H; Goltzman D; Hendy GN
J Biol Chem; 2012 Mar; 287(11):8584-97. PubMed ID: 22275377
[TBL] [Abstract][Full Text] [Related]
33. Mutation analysis in a Chinese family with multiple endocrine neoplasia type 1.
Zha BB; Liang W; Liu J; Cheng J; Hong XW; Liu J; Li YM; Ma D
Chin Med J (Engl); 2010 Mar; 123(5):569-73. PubMed ID: 20367983
[TBL] [Abstract][Full Text] [Related]
34. Genetic analysis of parathyroid and pancreatic tumors in a patient with multiple endocrine neoplasia type 1 using whole-exome sequencing.
Kim BY; Park MH; Woo HM; Jo HY; Kim JH; Choi HJ; Koo SK
BMC Med Genet; 2017 Oct; 18(1):106. PubMed ID: 28969599
[TBL] [Abstract][Full Text] [Related]
35. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
[TBL] [Abstract][Full Text] [Related]
36. A Novel Germline c.1267T>A
Gierlikowski W; Skwarek-Szewczyk A; Popow M
Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33233395
[TBL] [Abstract][Full Text] [Related]
37. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
[TBL] [Abstract][Full Text] [Related]
38. Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort study.
Thevenon J; Bourredjem A; Faivre L; Cardot-Bauters C; Calender A; Murat A; Giraud S; Niccoli P; Odou MF; Borson-Chazot F; Barlier A; Lombard-Bohas C; Clauser E; Tabarin A; Parfait B; Chabre O; Castermans E; Beckers A; Ruszniewski P; Le Bras M; Delemer B; Bouchard P; Guilhem I; Rohmer V; Goichot B; Caron P; Baudin E; Chanson P; Groussin L; Du Boullay H; Weryha G; Lecomte P; Penfornis A; Bihan H; Archambeaud F; Kerlan V; Duron F; Kuhn JM; Vergès B; Rodier M; Renard M; Sadoul JL; Binquet C; Goudet P
Hum Mol Genet; 2013 May; 22(10):1940-8. PubMed ID: 23376981
[TBL] [Abstract][Full Text] [Related]
39. Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.
Lemos MC; Thakker RV
Hum Mutat; 2008 Jan; 29(1):22-32. PubMed ID: 17879353
[TBL] [Abstract][Full Text] [Related]
40. A novel germline mutation, 1793delG, of the MEN1 gene underlying multiple endocrine neoplasia type 1.
Snabboon T; Plengpanich W; Siriwong S; Wisedopas N; Suwanwalaikorn S; Khovidhunkit W; Shotelersuk V
Jpn J Clin Oncol; 2005 May; 35(5):280-2. PubMed ID: 15894711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
